journal article·2020-07

Multifunctional STING‐Activating Mn3O4@Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy

Min Zhou, Xiaoyu Wang, Shichao Lin, Yuan Cheng, Sheng Zhao, Junshu Lin, Zhuoyao Fang, Zhangping Lou, Li Qin, Hui Wei

Advanced Healthcare Materials· Volume 9· Issue 13
Publisher page

Abstract

Abstract The promise of immunotherapy for cancer therapy has not been fully fulfilled because portions of tumors are immunosuppressive. To tackle this challenge, the initiation of immune system by stimulator of interferon genes (STING) pathway is explored and multifunctional STING‐activating nanoparticles are rationally designed for synergistic antitumor therapy. The STING‐activating nanoparticles have a formulation of Mn3O4@Au‐dsDNA/DOX, where dsDNA is used to activate STING for immunotherapy and doxorubicin (DOX) is chosen as a model drug for chemotherapy. The STING‐mediated immunity is activated, inducing interferon‐β (IFN‐β) production, increasing T cell priming, and enhancing effector T cell infiltration. Combined with chemotherapy, STING‐mediated immunotherapy shows good antitumor efficacy by inhibiting tumor growth and prolonging survival rate in vivo. The promise of cancer immunotherapy can be fulfilled by combining novel antitumor immunity with innovative nanotechnology, and chemotherapy and targeted therapies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · Immune cells in cancer · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Engineering and Applied Sciences Nanjing National Laboratory of Microstructures Jiangsu Key Laboratory of Artificial Functional Materials Nanjing University Nanjing Jiangsu 210093 China

Department of Biomaterials College of Materials Xiamen University Xiamen Fujian 361005 China

State Key Laboratory of Pollution Control and Resource Reuse School of the Environment Nanjing University Nanjing Jiangsu 210023 China

State Key Laboratory of Analytical Chemistry for Life Science State Key Laboratory of Coordination Chemistry School of Chemistry and Chemical Engineering Nanjing University Nanjing Jiangsu 210023 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · State Key Laboratory of Coordination Chemistry · Fundamental Research Funds for the Central Universities · National Basic Research Program of China

References (50)

Show source-provided references
1. 10.1126/science.aar406010.1126/science.aar4060 ↗
2. 10.1038/nrc.2017.1710.1038/nrc.2017.17 ↗
3. 10.1016/j.immuni.2015.11.02410.1016/j.immuni.2015.11.024 ↗
4. 10.1002/anie.20170155010.1002/anie.201701550 ↗
5. 10.1021/jacs.7b0789510.1021/jacs.7b07895 ↗
6. 10.1021/jacs.8b0107210.1021/jacs.8b01072 ↗
7. 10.1002/adma.20160603610.1002/adma.201606036 ↗
8. 10.1002/adma.20170609810.1002/adma.201706098 ↗
9. 10.1038/ncomms1319310.1038/ncomms13193 ↗
10. 10.1021/acs.nanolett.8b0217910.1021/acs.nanolett.8b02179 ↗
11. 10.1126/sciimmunol.aan569210.1126/sciimmunol.aan5692 ↗
12. 10.1002/anie.20171040710.1002/anie.201710407 ↗
13. 10.1038/s41573-018-0007-y10.1038/s41573-018-0007-y ↗
14. 10.1002/anie.20180488210.1002/anie.201804882 ↗
15. 10.1111/imr.1213210.1111/imr.12132 ↗
16. 10.1002/adma.20190019210.1002/adma.201900192 ↗
17. 10.1038/nri392110.1038/nri3921 ↗
18. 10.1073/pnas.121500610910.1073/pnas.1215006109 ↗
19. 10.1038/nature0731710.1038/nature07317 ↗
20. 10.1038/nature0847610.1038/nature08476 ↗
21. 10.1016/j.immuni.2008.09.00310.1016/j.immuni.2008.09.003 ↗
22. 10.1126/science.122996310.1126/science.1229963 ↗
23. 10.1038/nchembio.166110.1038/nchembio.1661 ↗
24. 10.1038/s41586-018-0705-y10.1038/s41586-018-0705-y ↗
25. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
26. 10.1016/j.ccell.2018.03.02710.1016/j.ccell.2018.03.027 ↗
27. 10.1158/2326-6066.CIR-15-006410.1158/2326-6066.CIR-15-0064 ↗
28. 10.1126/science.aav787110.1126/science.aav7871 ↗
29. 10.1038/nrc161310.1038/nrc1613 ↗
30. Kadiyala P. · ACS Nano · 2019 · 13 · 1365
31. 10.1021/acsnano.7b0090510.1021/acsnano.7b00905 ↗
32. 10.1021/jp806160g10.1021/jp806160g ↗
33. 10.1002/anie.20170857310.1002/anie.201708573 ↗
34. 10.1002/anie.20180553210.1002/anie.201805532 ↗
35. 10.1073/pnas.151283211210.1073/pnas.1512832112 ↗
36. 10.1158/0008-5472.CAN-16-140410.1158/0008-5472.CAN-16-1404 ↗
37. 10.1016/j.immuni.2014.11.00410.1016/j.immuni.2014.11.004 ↗
38. 10.1016/j.jconrel.2015.08.02610.1016/j.jconrel.2015.08.026 ↗
39. 10.1002/adbi.20160001310.1002/adbi.201600013 ↗
40. 10.1158/0008-5472.CAN-14-361910.1158/0008-5472.CAN-14-3619 ↗
41. 10.1038/s41467-019-13094-510.1038/s41467-019-13094-5 ↗
42. 10.1021/acs.nanolett.9b0409410.1021/acs.nanolett.9b04094 ↗
43. 10.1039/C7SC05476A10.1039/C7SC05476A ↗
44. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
45. 10.1002/adma.20180200610.1002/adma.201802006 ↗
46. 10.1021/jacs.8b0865810.1021/jacs.8b08658 ↗
47. 10.1038/onc.2016.22510.1038/onc.2016.225 ↗
48. 10.1186/s40169-019-0226-910.1186/s40169-019-0226-9 ↗
49. 10.1084/jem.2018013910.1084/jem.20180139 ↗
50. 10.1038/s41586-019-0885-010.1038/s41586-019-0885-0 ↗